Kinetics of venom and antivenom serum levels, clinical evaluation and therapeutic effectiveness in dogs inoculated with Crotalus durissus terrificus venom

this work evaluated the clinical and therapeutic aspects as well as serum levels of venom and antivenom igg by enzyme-linked immunosorbent assay (elisa) in experimental envenomation of dogs with crotalus durissus terrificus venom. twenty-eight mixed breed adult dogs were divided into four groups of seven animals each, group i: only venom; group ii, venom + 50 ml of anti-bothropic-crotalic serum (50mg) + fluid therapy; group iii, venom + 50 ml of anti-bothropic-crotalic serum + fluid therapy + urine alkalination; group iv, 50 ml of anti-bothropic-crotalic serum. the lyophilized venom of crotalus durissus terrificus was reconstituted in saline solution and subcutaneously inoculated at the dose of 1mg/kg body weight. the dogs presented clinical signs of local pain, weakness, mandibular ptosis, mydriasis, emesis and salivation. the venom levels detected by elisa ranged from 0 to 90ng/ml, according to the severity of the clinical signs. serum antivenom ranged from 0 to 3ug/ml and was detected for up to 138h after treatment. elisa results showed the effectiveness of the serum therapy for the venom neutralization.